TMCnet News
Novan to Present at Piper Jaffray 29th Annual Healthcare ConferenceMORRISVILLE, N.C., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that Nathan Stasko, PhD, President and Chief Scientific Officer of Novan, is scheduled to participate in a fireside chat at the Piper Jaffray 29th Annual Healthcare Conference, Wednesday, Nov. 29, 2017, 12:00 p.m. EST, in New York. The presentation will be webcast live and can be accessed through the Investor Relations section of the Company's website at www.Novan.com. n archived version of the webcast will be available approximately two hours following the live presentation for 30 days. About Novan Novan, Inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. We believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases. CONTACT: (Investors) (Media) |